Starton successfully delivers cancer drug using on-body injector

Starton Therapeutics has successfully demonstrated the use of BD’s on-body injector technology to deliver its low-dose lenalidomide formulation called STAR-LLD.

An on-body injector is a wearable device that delivers medication continuously under the skin through a tiny needle. It sticks to the body, allowing patients to receive controlled doses over time while going about their daily activities.